BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11433397)

  • 21. Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form.
    Shimomura T; Denda K; Kawaguchi T; Matsumoto K; Miyazawa K; Kitamura N
    J Biochem; 1999 Nov; 126(5):821-8. PubMed ID: 10544273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo.
    Miyata S; Uchinokura S; Fukushima T; Hamasuna R; Itoh H; Akiyama Y; Nakano S; Wakisaka S; Kataoka H
    Cancer Lett; 2005 Sep; 227(1):83-93. PubMed ID: 16051034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin genes and their promoters.
    Itoh H; Kataoka H; Meng JY; Hamasuna R; Kitamura N; Koono M
    Biochim Biophys Acta; 2001 May; 1519(1-2):92-5. PubMed ID: 11406276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 2.
    Qin L; Denda K; Shimomura T; Kawaguchi T; Kitamura N
    FEBS Lett; 1998 Sep; 436(1):111-4. PubMed ID: 9771903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
    Hashimoto T; Kato M; Shimomura T; Kitamura N
    FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis.
    Sasaki M; Ikeda H; Kataoka H; Nakanuma Y
    Virchows Arch; 2006 Oct; 449(4):462-71. PubMed ID: 16941151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
    Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H
    Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes.
    Itoh H; Yamauchi M; Kataoka H; Hamasuna R; Kitamura N; Koono M
    Eur J Biochem; 2000 Jun; 267(11):3351-9. PubMed ID: 10824123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
    Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
    Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible role of combined therapy targeting MET and pro-HGF activation for renal cell carcinoma: analysis by human HGF-producing SCID mice.
    Fujii M; Akioka T; Kimura S; Nagai T; Kiwaki T; Fukushima T; Mukai S; Kamoto T
    Hum Cell; 2023 Mar; 36(2):775-785. PubMed ID: 36708441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas.
    Fukushima T; Kawaguchi M; Yamamoto K; Yamashita F; Izumi A; Kaieda T; Takezaki Y; Itoh H; Takeshima H; Kataoka H
    Cancer Sci; 2018 Sep; 109(9):2970-2979. PubMed ID: 29987920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of hepatocyte growth factor activator inhibitor type 2 (HAI-2)-related small peptide (H2RSP): its nuclear localization and generation of chimeric mRNA transcribed from both HAI-2 and H2RSP genes.
    Itoh H; Kataoka H; Yamauchi M; Naganuma S; Akiyama Y; Nuki Y; Shimomura T; Miyazawa K; Kitamura N; Koono M
    Biochem Biophys Res Commun; 2001 Oct; 288(2):390-9. PubMed ID: 11606055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.
    Kirchhofer D; Peek M; Lipari MT; Billeci K; Fan B; Moran P
    FEBS Lett; 2005 Mar; 579(9):1945-50. PubMed ID: 15792801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.
    Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N
    J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro.
    Moriyama T; Kataoka H; Tsubouchi H; Koono M
    FEBS Lett; 1995 Sep; 372(1):78-82. PubMed ID: 7556648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.
    Oberst M; Anders J; Xie B; Singh B; Ossandon M; Johnson M; Dickson RB; Lin CY
    Am J Pathol; 2001 Apr; 158(4):1301-11. PubMed ID: 11290548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of vascular endothelial growth factor-b in human astrocytoma.
    Gollmer JC; Ladoux A; Gioanni J; Paquis P; Dubreuil A; Chatel M; Frelin C
    Neuro Oncol; 2000 Apr; 2(2):80-6. PubMed ID: 11303624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas.
    Kunkel P; Müller S; Schirmacher P; Stavrou D; Fillbrandt R; Westphal M; Lamszus K
    Neuro Oncol; 2001 Apr; 3(2):82-8. PubMed ID: 11296484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro.
    Desbaillets I; Tada M; de Tribolet N; Diserens AC; Hamou MF; Van Meir EG
    Int J Cancer; 1994 Jul; 58(2):240-7. PubMed ID: 7517920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth.
    Fan B; Brennan J; Grant D; Peale F; Rangell L; Kirchhofer D
    Dev Biol; 2007 Mar; 303(1):222-30. PubMed ID: 17174946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.